A multicentre, parallel group, study of LAX-101 (ethyl eicosapentaenoate [EPA]) in people with a new or recurrent episode of depression
This study is recruiting in the United Kingdom. It focuses on depression.
In United Kingdom
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United Kingdom. It focuses on depression.
In United KingdomThis study is recruiting in the United Kingdom. It is testing ethyl eicosapentaenoate (EPA) for Depression.
In United KingdomThis study is recruiting in the United Kingdom. It is testing ethyl-eicosapentaenoate (ethyl-EPA) for schizophrenia.
In United KingdomThis study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In United KingdomThis summary needs review. Please check the official study record and contact the research team for details.
In ParisThis summary needs review. Please check the official study record and contact the research team for details.
In SingaporeThis summary needs review. Please check the official study record and contact the research team for details.
In HoustonThis summary needs review. Please check the official study record and contact the research team for details.
In HoustonThis summary needs review. Please check the official study record and contact the research team for details.
In ProvidenceThis observational study is following people with Anxiety and Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In DurhamThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Zacatecas CityThis observational study is following people with depression, anxiety, or psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In New WestminsterHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.